Quantcast

Latest Barbara Ann Karmanos Cancer Institute Stories

2010-10-22 11:12:00

ADDRESSING NATIONAL SHORTAGE OF MINORITY CORD BLOOD DETROIT, Oct. 22 /PRNewswire-USNewswire/ -- The J.P. McCarthy Cord Stem Cell Bank at the Barbara Ann Karmanos Cancer Institute will receive a $1.4 million, three-year, contract award from the Department of Health and Human Services' Health Resources and Services Administration (HRSA) to expand its cord blood collection program. The contract will allow Karmanos to bank more genetically-diverse, high-quality umbilical cord blood units for...

2010-10-18 15:48:00

DETROIT, Oct. 18 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer - triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute. (Logo:...

2010-09-23 11:43:00

2010 Komen Detroit Race for the Cure® Accomplishments DETROIT, Sept. 23 /PRNewswire-USNewswire/ -- Susan G. Komen Detroit Race for the Cure® announced that it has awarded more than $1.5 million to local breast cancer education, screening and treatment programs as a result of $2.3 million raised in the 2010 Komen Detroit Race for the Cure®, locally presented by the Barbara Ann Karmanos Cancer Institute. The announcement was made...

2010-09-15 15:06:00

DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center in Detroit was recently selected to be one of 50 sites in the United States to offer the new U.S. Food and Drug Administration (FDA)-approved drug PROVENGE® (sipuleucel-T) to treat patients with advanced metastatic prostate cancer. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) PROVENGE, manufactured by...

2010-09-08 11:16:00

BEVERLY HILLS, Calif., Sept. 8 /PRNewswire/ -- Tower Cancer Research Foundation, a nonprofit organization dedicated to cutting edge cancer therapy and research, will host the first in a series of free symposiums on October 19. The 2010 Tower Oncology Fall Cancer Symposium - Advances in Breast Cancer Research and Treatment: A Multidisciplinary Panel Discussion - will take place from 6:30-8:30pm at Wolfgang's Steakhouse on 445 N. Canon Drive in Beverly Hills. The symposium will feature...

2010-06-15 07:00:00

TROY, Mich., June 15 /PRNewswire/ -- CareTech Solutions (www.caretech.com), an information technology (IT) and Web products and services provider for more than 150 hospitals nationwide, announced today the appointment of Michael Duggan, Detroit Medical Center president and CEO; and Jay Rising, Detroit Medical Center executive vice president and CFO, to the CareTech Solutions board of directors. A privately held company formed in 1998, CareTech Solutions is governed by a six-person board...

2010-06-06 14:00:00

CHICAGO, June 6 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, both in Detroit, and the Children's Hospital of Michigan/Detroit Medical Center, presented preliminary data that identified a potential link between Gilbert's Syndrome and the development of a specific subtype of childhood acute lymphoblastic leukemia (ALL). The findings were announced today at the 2010 American Society of Clinical Oncology...

2010-06-05 14:00:00

CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties. The findings were announced today at the 2010 American Society of Clinical Oncology...

2010-06-05 08:00:00

CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data showing that by combining two treatment agents in the care of multiple myeloma patients, doctors can use higher dosages of chemotherapy before autologous stem cell transplant while alleviating painful and debilitating side effects like severe oral mucositis (mouth ulcers). The findings were announced today at the 2010 American Society of Clinical Oncology Annual...

2010-06-02 13:13:00

DETROIT, June 2 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in cooperation with Blue Cross Blue Shield of Michigan and the U.S. Centers for Disease Control's Agency for Toxic Substances and Disease Registry (ATSDR), is introducing the Environmental Cancer Program to physicians statewide July 1. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) The program trains primary care physicians to accurately identify and diagnose cancers and other...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related